At the IGTP TODAY

News

- Innovation

Aniling chosen for an intensive preparation program for Boston

The IGTP-PMPPC applied health technology spin-off is one of five selected by ACCIÓ in the first edition of 'Road to Boston'. Aniling is one of five applied health technology Catalan start-ups that has started an intensive six-month tailored program to prepare for entry to Boston, one of the principal hubs in this field, to establish first contacts with key players in the sector.  

- Innovation

Researchers at Can Ruti Campus enter into a licence agreement for the worldwide rights to the use of biomarker soluble neprilysin (sNEP) for assessing risk stratification and prognosis of heart failure patients

23 April 2016.  The group led by Dr Antoni Bayés-Genís of the Department of Cardiology of the Germans Trias i Pujol Hospital (HUGTiP) and the Germans Trias i Pujol Health Research Institute (IGTP) have signed a licence agreement with the American Company Critical Diagnostics for biomarker soluble neprilysin (sNEP).